2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells, Clin. Cancer Res, vol.15, pp.4857-4866, 2009. ,
EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma, Cancer Res, vol.68, pp.7100-7109, 2008. ,
Hsa-mir-145 is the top EWS-FLI1 repressed microRNA involved in a positive feed-back loop in Ewing's sarcoma, Oncogene, vol.30, pp.2173-2180, 2010. ,
Notch signaling is off and is uncoupled from HES1 expression in Ewing's sarcoma, J. Pathol, vol.225, pp.353-363, 2011. ,
Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma, Int. J. Cancer, 2012. ,
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling, Nature, vol.476, pp.293-297, 2011. ,
Metformin: multifaceted protection against cancer, Oncotarget, vol.2, pp.896-917, 2011. ,
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours, Nature, vol.359, pp.162-165, 1992. ,
Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group, Pediatr. Blood Cancer, vol.52, pp.324-327, 2009. ,
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma, Nat. Med, vol.15, pp.750-756, 2009. ,
Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors, Cell Cycle, vol.10, pp.3397-3408, 2011. ,
Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition, Cancer Cell, vol.15, pp.402-415, 2009. ,
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling, Oncogene, vol.30, pp.2730-2740, 2011. ,
Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening, J. Natl. Cancer Inst, vol.103, pp.962-978, 2011. ,
, STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors, vol.10, pp.52-65, 2012.
High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients, Ann. Oncol, 2012. ,
Prognostic impact of chromosomal aberrations in Ewing tumours, Br. J. Cancer, vol.86, pp.1763-1769, 2002. ,
Targeting of insulin-like growth factor type 1 receptor in Ewing sarcoma: unfulfilled promise or a promising beginning?, J. Clin. Oncol, vol.29, pp.4581-4583, 2011. ,
Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology, Acta Neuropathol, vol.122, pp.657-671, 2011. ,
CD133 expression in chemo-resistant Ewing sarcoma cells, BMC Cancer, vol.10, p.116, 2010. ,
The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHCindependent immune targeting, Br. J. Cancer, vol.106, pp.1123-1133, 2012. ,
Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses, Cancer Immunol. Immunother, vol.61, pp.127-135, 2012. ,
Mithramycin in the treatment of metastatic Ewing's sarcoma, Cancer, vol.31, pp.889-893, 1973. ,
Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-EWING 99 Trial, J. Clin. Oncol, vol.28, pp.1982-1988, 2010. ,
EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model, Cancer Res, vol.68, pp.8968-8975, 2008. ,
Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosisinducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity, Am. J. Pathol, vol.170, pp.1917-1930, 2007. ,
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma, Blood, vol.118, pp.6050-6056, 2011. ,
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma, Oncogene, vol.31, pp.1287-1298, 2011. ,
Modeling metastasis biology and therapy in real time in the mouse lung, J. Clin. Invest, vol.120, pp.2979-2988, 2010. ,
Cytoplasmic MTDH provides a survival advantage under conditions of stress by acting as an RNA binding protein, J. Biol. Chem, vol.287, pp.4485-4491, 2011. ,
Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma, Cancer Res, vol.64, pp.8349-8356, 2004. ,
The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse, Cell Stem Cell, vol.8, pp.511-524, 2011. ,
Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4, Nature, vol.464, pp.792-796, 2010. ,
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemosensitivity and malignancy, J. Pathol, vol.226, pp.796-805, 2011. ,
, , 2012.
, The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis, Cell Death Differ, vol.19, pp.501-510
Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients, Cancer Res, vol.70, pp.7610-7619, 2010. ,
Treating cancer with genetically engineered T cells, Trends Biotechnol, vol.29, pp.550-557, 2011. ,
A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanisms, Mol. Cancer Res, vol.10, pp.336-346, 2012. ,
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma, Nat. Genet, vol.44, pp.323-327, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02438686
Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas, Cancer Res, vol.70, pp.8770-8781, 2010. ,
Enhanced poly (adenosine diphosphate ribose) polymerase activity and gene expression in Ewing's sarcoma cells, Cancer Res, vol.50, pp.38-43, 1990. ,
Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group, Genes Chromosomes Cancer, vol.47, pp.207-220, 2008. ,
Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors, BMC Cancer, vol.9, p.17, 2009. ,
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma, PLoS Med, vol.4, p.122, 2007. ,
Identification of cancer stem cells in Ewing's sarcoma, Cancer Res, vol.69, pp.1776-1781, 2009. ,
Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells, Br. J. Cancer, vol.104, pp.948-956, 2011. ,
LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines, PLoS ONE, vol.6, p.22733, 2011. ,
Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB, Cancer Res, vol.63, pp.1122-1129, 2003. ,